Treatment of anemia in elderly patients receiving first-line chemotherapy for advanced lung cancer: Analysis of an unselected population

被引：0
|
作者：
Mansueto, G
Gareri, R
Buccilli, A
Trapasso, T
Giampaolo, M
Gamucci, T
机构：
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)81024-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S257 / S257
页数：1
相关论文
共 50 条
  • [31] EFFICACY AND FEASIBILITY OF GEMCITABINE AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Lim, K.
    Lee, W.
    Kim, K.
    Lee, H.
    Han, S.
    Song, S.
    Kim, W. J.
    Lee, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S70 - S70
  • [32] Efficacy and feasibility of gemcitabine and carboplatin as first-line chemotherapy in elderly patients with advanced non-small cell lung cancer
    Lim, Kyu-Hyoung
    Lee, Hui-Young
    Song, Seo-Young
    [J]. CHINESE MEDICAL JOURNAL, 2013, 126 (24) : 4644 - 4648
  • [33] Efficacy and feasibility of gemcitabine and carboplatin as first-line chemotherapy in elderly patients with advanced non-small cell lung cancer
    Kyu-Hyoung Lim
    Hui-Young Lee
    Seo-Young Song
    [J]. 中华医学杂志(英文版), 2013, 126 (24) : 4644 - 4648
  • [34] Prognostic Impact of KRAS Mutational Status in Patients with Advanced Lung Adenocarcinoma Receiving First-Line Cytotoxic Chemotherapy
    Desai, Arpita
    He, Xiangyun
    Gandhi, Shipra
    Wang, Chong
    Meagher, Alison
    Dy, Grace K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S421 - S421
  • [35] Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapy
    Fonseca, Paula J.
    Esteban, Emilio
    de Vicente, Pilar
    Luque, Maria
    Llorente, Beatriz
    Capelan, Marta
    Berros, Jose Pablo
    Crespo, Guillermo
    Lacave, Angle J.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (07): : 426 - 432
  • [36] Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapy
    Paula J. Fonseca
    Emilio Esteban
    Pilar de Vicente
    María Luque
    Beatriz Llorente
    Marta Capelán
    José Pablo Berros
    Guillermo Crespo
    Ángel J. Lacave
    [J]. Clinical and Translational Oncology, 2008, 10 : 426 - 432
  • [37] Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
    Suzuki, Yuko
    Kan, Motoyasu
    Kimura, Gen
    Umemoto, Kumiko
    Watanabe, Kazuo
    Sasaki, Mitsuhito
    Takahashi, Hideaki
    Hashimoto, Yusuke
    Imaoka, Hiroshi
    Ohno, Izumi
    Mitsunaga, Shuichi
    Ikeda, Masafumi
    [J]. JOURNAL OF GASTROENTEROLOGY, 2019, 54 (03) : 281 - 290
  • [38] Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
    Yuko Suzuki
    Motoyasu Kan
    Gen Kimura
    Kumiko Umemoto
    Kazuo Watanabe
    Mitsuhito Sasaki
    Hideaki Takahashi
    Yusuke Hashimoto
    Hiroshi Imaoka
    Izumi Ohno
    Shuichi Mitsunaga
    Masafumi Ikeda
    [J]. Journal of Gastroenterology, 2019, 54 : 281 - 290
  • [39] Intraperitoneal chemotherapy in first-line combination treatment for advanced ovarian cancer
    Massard, Christophe
    Lhomme, Catherine
    Pautier, Patricia
    [J]. BULLETIN DU CANCER, 2007, 94 (04) : 398 - 404
  • [40] First-line treatment in elderly patients
    Montefusco, V.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S19 - S19
12345